Proviera Biotech
Kansas City, US · Founded 2012 · 1 known investors
Proviera makes the ProLagen line of wetting, dispersing, and degreasing products used in early-stage hide processing for leather, removing the need for bactericides while preserving collagen fiber quality. Its process aims to improve the quality of the collagen by-product and the performance of hides in leather production.
Advanced ManufacturingNew Materials
Founders & leadership
MW
Matthew WoodNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$1M disclosed across 1 round · 2014
▶$1MraisedMar 2014 · 7 investors · Other TechnologyRule 506(b)
▶$1MraisedMar 2014 · 7 investors · Other Technology
Rule 506(b)Officers, directors & promoters on the filing
- Matthew WoodExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1M
- First sale
- Feb 2014
- Incorporated
- Limited Liability Company, Missouri, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 1
by search overlapCompanies competing with Proviera Biotech for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Proviera Biotech do?
- Proviera makes the ProLagen line of wetting, dispersing, and degreasing products used in early-stage hide processing for leather, removing the need for bactericides while preserving collagen fiber quality. Its process aims to improve the quality of the collagen by-product and the performance of hides in leather production.
- Who are Proviera Biotech's investors?
- Proviera Biotech's investors include Missouri Technology Corporation.
- How much funding has Proviera Biotech raised?
- Proviera Biotech has disclosed $1M raised across 1 round.
- Where is Proviera Biotech headquartered?
- Proviera Biotech is headquartered in Kansas City, US.